The effect of Urtica Dioica (Nettle), Vaccinium myrtillus on type 2 diabetes

Phase 3

Recruiting

Conditions: Type 2 diabetes.
Diabetes mellitus due to underlying condition

Registration Number: IRCT20140617018126N3

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Type 2 diabetes
Taking hypoglycemic drugs (people who control their diabetes just by taking blood sugar-lowering drug)
Age 40-70 years
Body mass index 18.5–30 kg / m 2
Fasting blood sugar equal to or more than 126 mg / d

Exclusion Criteria

Type 1 diabetes
Other specific types of diabetes
Insulin therapy over the past three months
Having serious gastrointestinal diseases (GI) including gastric ulcers and gastrointestinal bleeding
Have a history of diabetic ketoacidosis, non-ketotic hyperosmolar diabetic coma, severe infection or surgery in the previous month
Uncontrolled high blood pressure (Blood pressure higher or equal to 160/100 mm Hg)
mental illness
Abuse or addiction to alcohol, psychoactive substances or other drugs
Pregnancy, lactation or plan to become pregnant
Having cardiovascular disease, renal insufficiency, liver dysfunction, thyroid dysfunction, parathyroid dysfunction, and cancers
High physical activity
Chronic complications of diabetes (neuropathy, retinopathy, according to patient records), diabetic nephropathy, hypothyroidism and hyperthyroidism
Sensitivity to Nettle and Vaccinium myrtillus

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting Blood Sugar. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting Blood Sugar Test.

Secondary Outcome Measures

Name	Time	Method
HbA1C. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: HbA1C test.;Creatinine. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Creatinine Test.;Fasting Insulin. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting Insulin Blood Test.;Cholesterol. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Cholesterol Test.;Triglyceride. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Triglyceride Test.